Comparison of health-related quality of life among patients using atypical antipsychotics for treatment of depression: results from the National Health and Wellness Survey
<p>Abstract</p> <p>Background</p> <p>Use of atypical antipsychotics (AA) in combination with an antidepressant is recommended as an augmentation strategy for patients with depression. However, there is a paucity of data comparing aripiprazole and other AAs in terms of p...
Main Authors: | Kalsekar Iftekhar, Wagner Jan-Samuel, DiBonaventura Marco, Bates Jay, Forbes Robert, Hebden Tony |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-07-01
|
Series: | Health and Quality of Life Outcomes |
Online Access: | http://www.hqlo.com/content/10/1/81 |
Similar Items
-
Medical costs and utilization in patients with depression treated with adjunctive atypical antipsychotic therapy
by: Nadkarni A, et al.
Published: (2013-01-01) -
Evaluating the health and economic impact of osteoarthritis pain in the workforce: results from the National Health and Wellness Survey
by: McDonald Margaret, et al.
Published: (2011-04-01) -
Atypical antipsychotics:
by: Claudia Aparecida Avelar Ferreira, et al.
Published: (2015-10-01) -
Atypical antipsychotics as add-on treatment in late-life depression
by: Cakir S, et al.
Published: (2016-09-01) -
The effects of antipsychotic drugs on depression level in patients with schizophrenia: clozapine vs. other atypical antipsychotics
by: Burkay Yakar, et al.
Published: (2016-08-01)